20 Patients with a primary musculo skeletal tumor were investigated by MRI to assess the efficacy of Gd DOTA. The essential contribution is that it distinguishes the active parts of the lesion, intratumoral necrosis or sequelae cavities that do not take up the contrast medium. The injection does not allow for differentiation between tumor recurrence and treatment-induced inflammatory abnormality.
|Translated title of the contribution||Contribution of Gadolinium DOTA in 20 primary bone and soft tissue tumors|
|Number of pages||5|
|Journal||Journal de Radiologie|
|Publication status||Published - 1988|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology